Gut microbiota dependent anti-tumor immunity restricts melanoma growth in Rnf5−/− mice
Open accessThe DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Abstract
Accumulating evidence points to an important role for the gut microbiome in anti-tumor immunity. Here, we show that altered intestinal microbiota contributes to anti-tumor immunity, limiting tumor expansion. Mice lacking the ubiquitin ligase RNF5 exhibit attenuated activation of the unfolded protein response (UPR) components, which coincides with increased expression of inflammasome components, recruitment and activation of dendritic cells and reduced expression of antimicrobial peptides in intestinal epithelial cells. Reduced UPR expression is also seen in murine and human melanoma tumor specimens that responded to immune checkpoint therapy. Co-housing of Rnf5 −/− and WT mice abolishes the anti-tumor immunity and tumor inhibition phenotype, whereas transfer of 11 bacterial strains, including B. rodentium , enriched in Rnf5 −/− mice, establishes anti-tumor immunity and restricts melanoma growth in germ-free WT mice. Altered UPR signaling, exemplified in Rnf5 −/− mice, coincides with altered gut microbiota composition and anti-tumor immunity to control melanoma growth.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Homeostasis of gut microbiota also affects the efficacy and side effects of common cancer treatments, such as chemotherapy, radiotherapy, and immunotherapy8,9.”
From Combining gut microbiota modulation and chemotherapy by capecitabine-loaded prebiotic nanoparticle improves colorectal cancer therapy (2023) · cites this paper as [8]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Non-hematopoietic components of the intestinal mucosa are also linked to the TME (77).”
From The microbiome and human cancer (2021) · cites this paper as [77]
The cited source says what the claim attributes to it.
In the citing paper
“Confirming a Rnf5−/−-specific microbial effect, co-housing Rnf5−/− mice with wild type mice, or administering antibiotics, restored tumor aggressiveness”
From The microbiome and human cancer (2021) · cites this paper as [77]
In the citing paper
“This bowel injury amplified mobilization of CCR7-expressing DCs to Peyer’s patches, mLNs and melanoma-draining LNs, increasing IFNγ-producing T lymphocyte tumor infiltration.”
From The microbiome and human cancer (2021) · cites this paper as [77]
In the citing paper
“Gene deficient mice and BM chimeras identified a role for RNF5, an E3 ubiquitin ligase, in immunosurveillance of severe melanoma.”
From The microbiome and human cancer (2021) · cites this paper as [77]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Genome engineering using the CRISPR-Cas9 system
Ran, F. A., Hsu, P. D., Wright, J., Agarwala, V., Scott, D. A., & Zhang, F. (2013) · Nature Protocols · doi:10.1038/nprot.2013.143 · Cited by 11,133
Commensal Bifidobacterium promotes antitumor immunity and facilitates anti–PD-L1 efficacy
Sivan, A., Corrales, L., Hubert, N., Williams, J. B., Aquino-Michaels, K., Earley, Z. M., Benyamin, F. W., Man Lei, Y., Jabri, B., Alegre, M.-L., et al. (2015) · Science · doi:10.1126/science.aac4255 · Cited by 3,888
Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota
Vétizou, M., Pitt, J. M., Daillère, R., Lepage, P., Waldschmitt, N., Flament, C., Rusakiewicz, S., Routy, B., Roberti, M. P., Duong, C. P. M., et al. (2015) · Science · doi:10.1126/science.aad1329 · Cited by 3,488
An Integrated Stress Response Regulates Amino Acid Metabolism and Resistance to Oxidative Stress
Harding, H. P., Zhang, Y., Zeng, H., Novoa, I., Lu, P. D., Calfon, M., Sadri, N., Yun, C., Popko, B., Paules, R., et al. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00105-9 · Cited by 3,323
Immune checkpoint targeting in cancer therapy: toward combination strategies with curative potential
Sharma, P., & Allison, J. P. (2015) · Cell · doi:10.1016/j.cell.2015.03.030 · Cited by 2,345
Role of the gut microbiota in immunity and inflammatory disease
Kamada, N., Seo, S.-U., Chen, G. Y., & Núñez, G. (2013) · Nature reviews. Immunology · doi:10.1038/nri3430 · Cited by 2,256
Targeted Disruption of the MyD88 Gene Results in Loss of IL-1- and IL-18-Mediated Function
Adachi, O., Kawai, T., Takeda, K., Matsumoto, M., Tsutsui, H., Sakagami, M., Nakanishi, K., & Akira, S. (1998) · Immunity · doi:10.1016/s1074-7613(00)80596-8 · Cited by 2,041
Lee, A.-H., Iwakoshi, N. N., & Glimcher, L. H. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.21.7448-7459.2003 · Cited by 2,037
NLRP6 Inflammasome Regulates Colonic Microbial Ecology and Risk for Colitis
Elinav, E., Strowig, T., Kau, A. L., Henao-Mejia, J., Thaiss, C. A., Booth, C. J., Peaper, D. R., Bertin, J., Eisenbarth, S. C., Gordon, J. I., et al. (2011) · Cell · doi:10.1016/j.cell.2011.04.022 · Cited by 2,024
TURNER, S., PRYER, K. M., MIAO, V. P. W., & PALMER, J. D. (1999) · Journal of Eukaryotic Microbiology · doi:10.1111/j.1550-7408.1999.tb04612.x · Cited by 1,575
Cited by
Endoplasmic reticulum stress signals in the tumour and its microenvironment
Chen, X., & Cubillos-Ruiz, J. R. (2021) · Nature Reviews Cancer · doi:10.1038/s41568-020-00312-2 · Cited by 1,356
The microbiome and human cancer
Sepich-Poore, G. D., Zitvogel, L., Straussman, R., Hasty, J., Wargo, J. A., & Knight, R. (2021) · Science · doi:10.1126/science.abc4552 · Cited by 1,332
“Nonhematopoietic components of the intestinal mucosa are also linked to the TME (77).”
InfluentialTumor-resident intracellular microbiota promotes metastatic colonization in breast cancer
Fu, A., Yao, B., Dong, T., Chen, Y., Yao, J., Liu, Y., Li, H., Bai, H., Liu, X., Zhang, Y., et al. (2022) · Cell · doi:10.1016/j.cell.2022.02.027 · Cited by 981
Gut microbiota in colorectal cancer development and therapy
Wong, C. C., & Yu, J. (2023) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-023-00766-x · Cited by 721
Current Sampling Methods for Gut Microbiota: A Call for More Precise Devices
Tang, Q., Jin, G., Wang, G., Liu, T., Liu, X., Wang, B., & Cao, H. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00151 · Cited by 455
“…infection from various pathogens; promoting the maturation of the immune system; participating in the regulation of the immune response, nutritional absorption and metabolism; and promoting anti-cancer functions (Foster et al., 2017; Kim et al., 2017; Macpherson et al., 2017; Li et al., 2019).”
Metadata
- Authors
- Li, Y., Tinoco, R., Elmén, L., Segota, I., Xian, Y., Fujita, Y., Sahu, A., Zarecki, R., Marie, K., Feng, Y., Khateb, A., Frederick, D. T., Ashkenazi, S. K., Kim, H., Perez, E. G., Day, C.-P., Segura Muñoz, R. S., Schmaltz, R., Yooseph, S., Tam, M. A., Zhang, T., Avitan-Hersh, E., Tzur, L., Roizman, S., Boyango, I., Bar-Sela, G., Orian, A., Kaufman, R. J., Bosenberg, M., Goding, C. R., Baaten, B., Levesque, M. P., Dummer, R., Brown, K., Merlino, G., Ruppin, E., Flaherty, K., Ramer-Tait, A., Long, T., Peterson, S. N., Bradley, L. M., & Ronai, Z. A.
- Affiliations
- Sanford Burnham Prebys Medical Discovery Institute (US)
- University of Nebraska–Lincoln (US)
- University of Maryland, College Park (US)
- Tel Aviv University (IL)
- National Institutes of Health (US)
- Technion – Israel Institute of Technology (IL)
- Harvard University (US)
- University of Central Florida (US)
- BioLegend (United States) (US)
- National Cancer Institute (US)
- Yale University (US)
- University of Oxford (GB)
- University of Zurich (CH)
- Corresponding author
- Ronai, Ze’ev A.
- ORCID
- Tinoco, Roberto
- Xian, Yibo
- Fujita, Yu
- Sahu, Avinash
- Zarecki, Raphy
- Marie, Kerrie
- Frederick, Dennie T.
- Kim, Hyungsoo
- Day, Chi-Ping
- Yooseph, Shibu
- Tam, Miguel A.
- Zhang, Tongwu
- Orian, Amir
- Kaufman, Randal J.
- Bosenberg, Marcus
- Goding, Colin R.
- Levesque, Mitchell P.
- Dummer, Reinhard
- Brown, Kevin
- Merlino, Glenn
- Ruppin, Eytan
- Flaherty, Keith
- Ramer-Tait, Amanda
- Long, Tao
- Bradley, Linda M.
- Ronai, Ze’ev A.
- Venue
- Nature Communications
- Published
- 2019-04-02
- Volume
- 10
- Issue
- 1
- Pages
- 1492-1492
- ISSN
- 2041-1723 (ISSN-L)
- PMC
- PMC6445090
- OpenAlex
- W2930205604
- Cited by
- 212
- References
- 50
- Citations by year
- 2026: 13 · 2025: 23 · 2024: 37 · 2023: 35 · 2022: 41 · 2021: 36 · 2020: 21 · 2019: 6
- FWCI
- 8.60
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Nature Communications (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Zurich Open Repository and Archive (University of Zurich) (acceptedVersion, cc-by)
- Lincoln (University of Nebraska) (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- eScholarship (California Digital Library) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion, cc-by)
- Research Explorer (The University of Manchester) (submittedVersion, other-oa)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion, cc-by)
- Zurich Open Repository and Archive (University of Zurich)
- Funders
- Melanoma Research Alliance (509524)
- National Institutes of Health (CA030199)
- Engineering and Physical Sciences Research Council (EP/K040375/1)
- National Cancer Institute (R35CA197465, DK103185, CA198103, CA 030199, R01CA198103, P01CA128814, R01CA216187, P30CA030199)
- National Institute of Allergy and Infectious Diseases (R01AI106895)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK113171, R01DK103185)
- Congressionally Directed Medical Research Programs (CA150892)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- gut microbiota, antitumor immunity, melanoma, RNF5, ubiquitin ligase, unfolded protein response, inflammasome, dendritic cells, antimicrobial peptides, immune checkpoint therapy, germ-free mice, cohousing
- MeSH terms
- Gastrointestinal Microbiome, Animals, Bacteria, Humans, Intestines, Melanoma, Membrane Proteins, Mice, Inbred C57BL, Mice, Knockout, Antimicrobial Cationic Peptides, Ubiquitin-Protein Ligases, Cell Proliferation, Mice, Unfolded Protein Response
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Gut microbiota dependent anti-tumor immunity restricts melanoma growth in Rnf5−/− mice. https://app.cochat.ai/papers/10.1038/s41467-019-09525-y
- The paper
- Li, Y., Tinoco, R., Elmén, L., Segota, I., Xian, Y., Fujita, Y., Sahu, A., Zarecki, R., Marie, K., Feng, Y., Khateb, A., Frederick, D. T., Ashkenazi, S. K., Kim, H., Perez, E. G., Day, C.-P., Segura Muñoz, R. S., Schmaltz, R., Yooseph, S., . . . Ronai, Z. A. (2019). Gut microbiota dependent anti-tumor immunity restricts melanoma growth in Rnf5−/− mice. Nature Communications. https://doi.org/10.1038/s41467-019-09525-y
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.